publication . Article . 2017

Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia.

Rui Lu; Rui Lu; Gang Greg Wang; Gang Greg Wang;
Open Access English
  • Published: 01 Oct 2017 Journal: Frontiers in Oncology (issn: 2234-943X, Copyright policy)
  • Publisher: Frontiers Media S.A.
Acute myeloid leukemia (AML), a common hematological cancer of myeloid lineage cells, generally exhibits poor prognosis in the clinic and demands new treatment options. Recently, direct sequencing of samples from human AMLs and pre-leukemic diseases has unveiled their mutational landscapes and significantly advanced the molecular understanding of AML pathogenesis. The newly identified recurrent mutations frequently “hit” genes encoding epigenetic modulators, a wide range of chromatin-modifying enzymes and regulatory factors involved in gene expression regulation, supporting aberration of chromatin structure and epigenetic modification as a main oncogenic mechani...
Medical Subject Headings: hemic and lymphatic diseases
free text keywords: epigenetic modulator, small-molecule inhibitors, acute myeloid leukemia, bromodomain, MLL, EZH2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Mini Review, DNMT3A, Cancer Research, Oncology, Biology, DOT1L, Histone methyltransferase, Chromatin, Chromatin remodeling, KMT2A, biology.protein, Epigenetics, Myeloid leukemia, Demethylase
Funded by
NIH| Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple Myeloma
  • Funder: National Institutes of Health (NIH)
  • Project Code: 5R01CA211336-02
NIH| Determining the Role of DNA Methylation Deregulation in Oncogenesis
  • Funder: National Institutes of Health (NIH)
  • Project Code: 1R01CA215284-01
131 references, page 1 of 9

1 Strahl BD Allis CD. The language of covalent histone modifications. Nature (2000) 403(6765):41–5.10.1038/47412 10638745 [OpenAIRE] [PubMed] [DOI]

2 Chi P Allis CD Wang GG Covalent histone modifications – miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer (2010) 10(7):457–69.10.1038/nrc2876 20574448 [OpenAIRE] [PubMed] [DOI]

3 Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol (2010) 28(10):1079–88.10.1038/nbt.1684 20944600 [OpenAIRE] [PubMed] [DOI]

4 Portela A Esteller M Epigenetic modifications and human disease. Nat Biotechnol (2010) 28(10):1057–68.10.1038/nbt.1685 20944598 [OpenAIRE] [PubMed] [DOI]

5 Dawson MA Kouzarides T Cancer epigenetics: from mechanism to therapy. Cell (2012) 150(1):12–27.10.1016/j.cell.2012.06.013 22770212 [OpenAIRE] [PubMed] [DOI]

6 Baylin SB Jones PA. A decade of exploring the cancer epigenome – biological and translational implications. Nat Rev Cancer (2011) 11(10):726–34.10.1038/nrc3130 21941284 [OpenAIRE] [PubMed] [DOI]

7 Schwartzentruber J Korshunov A Liu XY Jones DT Pfaff E Jacob K Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature (2012) 482(7384):226–31.10.1038/nature10833 22286061 [OpenAIRE] [PubMed] [DOI]

8 Abdel-Wahab O Levine RL. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood (2013) 121(18):3563–72.10.1182/blood-2013-01-451781 23640996 [OpenAIRE] [PubMed] [DOI]

9 Garraway LA Lander ES Lessons from the cancer genome. Cell (2013) 153(1):17–37.10.1016/j.cell.2013.03.002 23540688 [OpenAIRE] [PubMed] [DOI]

10 Estey E Dohner H. Acute myeloid leukaemia. Lancet (2006) 368(9550):1894–907.10.1016/S0140-6736(06)69780-8 17126723 [PubMed] [DOI]

11 Khwaja A Bjorkholm M Gale RE Levine RL Jordan CT Ehninger G Acute myeloid leukaemia. Nat Rev Dis Primers (2016) 2:16010 10.1038/nrdp.2016.10 27159408 [PubMed] [DOI]

12 Kroon E Thorsteinsdottir U Mayotte N Nakamura T Sauvageau G. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J (2001) 20(3):350–61.10.1093/emboj/20.3.350 11157742 [OpenAIRE] [PubMed] [DOI]

13 Wang GG Pasillas MP Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood (2005) 106(1):254–64.10.1182/blood-2004-12-4664 15755900 [OpenAIRE] [PubMed] [DOI]

14 Alharbi RA Pettengell R Pandha HS Morgan R. The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia (2013) 27(5):1000–8.10.1038/leu.2012.356 23212154 [OpenAIRE] [PubMed] [DOI]

15 Ley TJ Ding L Walter MJ McLellan MD Lamprecht T Larson DE DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 363(25):2424–33.10.1056/NEJMoa1005143 21067377 [OpenAIRE] [PubMed] [DOI]

131 references, page 1 of 9
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue